Published by Iain Gilbert on 17th October 2018
(Sharecast News) - Clinical stage biotechnology company ValiRx's leading anti-cancer therapeutic has entered the concluding stages of its Phase l/ll clinical trial at University College London Hospital.
URL: http://www.digitallook.com/dl/news/story/28147889/...